ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. HD
6. DVLT
7. LOW
8. MRK
9. PGR
10. EPM

Go back to ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure
RESMED, Inc. (NYSE: RMD) Delayed: 229.99 +10.01 (4.55%)
Previous Close $219.98    52 Week High $70.90 
Open $221.00    52 Week Low $50.77 
Day High $230.10    P/E 103.13 
Day Low $220.44    EPS $2.23 
Volume 670,564       

Resmed, Inc. (AMEX: RSMDF) Delayed: 22.48 --0 (-0%)
Previous Close $22.48    52 Week High $6.68 
Open $22.48    52 Week Low $5.13 
Day High $22.48    P/E N/A 
Day Low $22.48    EPS $0.00 
Volume 174,561